These studies started years ago. Yep, agree on dru
Post# of 154134
That's also the key difference too --- getting results on using LAL + AAV Vector delivery
Then piggybacking into LL-PLS/Vector for the FcRn & cancer patent also....i would think Hiv-MDR has less competitors
I think his work is not for Cytodyn to go into Hiv themselves or at least even alone

